Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Combe

Showing results (141-150 of 282) with videos related to

Pageof 29
Sort By:
Clinical and Experimental Rheumatology|September 8, 2020
Three-year clinical outcomes in patients with rheumatoid arthritis treated with certolizumab pegol: results from the observational ECLAIR studyAlain Saraux, Bernard Combe, Francis Fagnani, et al.
Joint Bone Spine|July 3, 2014
Recommendations of the French Society for Rheumatology for managing rheumatoid arthritisCécile Gaujoux-Viala, Laure Gossec, Alain Cantagrel, et al.
The Journal of Rheumatology|December 17, 2019
Association Between Vitamin D Deficiency and Disease Activity, Disability, and Radiographic Progression in Early Rheumatoid Arthritis: The ESPOIR CohortGaël Mouterde, Etienne Gamon, Nathalie Rincheval, et al.
Annals of the Rheumatic Diseases|April 8, 2022
Safety of ixekizumab in patients with psoriatic arthritis: data from four clinical trials with over 2000 patient-years of exposureAtul A Deodhar, Bernard Combe, Ana P Accioly, et al.
Annals of the Rheumatic Diseases|June 1, 2010
A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trialMaxime Dougados, Bernard Combe, Jürgen Braun, et al.
RMD Open|July 26, 2024
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND studyRoy Fleischmann, Sebastian Meerwein, Christina Charles-Schoeman, et al.
RMD Open|October 27, 2017
Variants of genes implicated in type 1 interferon pathway and B-cell activation modulate the EULAR response to rituximab at 24 weeks in rheumatoid arthritisPierre-Antoine Juge, Steven Gazal, Arnaud Constantin, et al.
Joint Bone Spine|January 14, 2014
Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritisDaniel Wendling, Cédric Lukas, Julien Paccou, et al.
Rheumatology (Oxford, England)|February 19, 2009
Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study)Bernard Combe, Gary Swergold, James McLay, et al.
Rheumatology (Oxford, England)|May 16, 2021
Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abataceptClaire Rempenault, Cédric Lukas, Bernard Combe, et al.
Pageof 29

Showing results (141-150 of 282) with videos related to

Sort By:
Pageof 29
Clinical and Experimental Rheumatology|September 8, 2020
Three-year clinical outcomes in patients with rheumatoid arthritis treated with certolizumab pegol: results from the observational ECLAIR studyAlain Saraux, Bernard Combe, Francis Fagnani, et al.
Joint Bone Spine|July 3, 2014
Recommendations of the French Society for Rheumatology for managing rheumatoid arthritisCécile Gaujoux-Viala, Laure Gossec, Alain Cantagrel, et al.
The Journal of Rheumatology|December 17, 2019
Association Between Vitamin D Deficiency and Disease Activity, Disability, and Radiographic Progression in Early Rheumatoid Arthritis: The ESPOIR CohortGaël Mouterde, Etienne Gamon, Nathalie Rincheval, et al.
Annals of the Rheumatic Diseases|April 8, 2022
Safety of ixekizumab in patients with psoriatic arthritis: data from four clinical trials with over 2000 patient-years of exposureAtul A Deodhar, Bernard Combe, Ana P Accioly, et al.
Annals of the Rheumatic Diseases|June 1, 2010
A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trialMaxime Dougados, Bernard Combe, Jürgen Braun, et al.
RMD Open|July 26, 2024
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND studyRoy Fleischmann, Sebastian Meerwein, Christina Charles-Schoeman, et al.
RMD Open|October 27, 2017
Variants of genes implicated in type 1 interferon pathway and B-cell activation modulate the EULAR response to rituximab at 24 weeks in rheumatoid arthritisPierre-Antoine Juge, Steven Gazal, Arnaud Constantin, et al.
Joint Bone Spine|January 14, 2014
Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritisDaniel Wendling, Cédric Lukas, Julien Paccou, et al.
Rheumatology (Oxford, England)|February 19, 2009
Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study)Bernard Combe, Gary Swergold, James McLay, et al.
Rheumatology (Oxford, England)|May 16, 2021
Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abataceptClaire Rempenault, Cédric Lukas, Bernard Combe, et al.
Pageof 29